false
0000744452
0000744452
2026-05-26
2026-05-26
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
Amendment No. 1
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
May 26, 2026
BNB Plus Corp.
(Exact name of registrant as specified in its charter)
|
Delaware
(State or other jurisdiction
of incorporation) |
001-36745
(Commission File Number) |
59-2262718
(IRS Employer
Identification No.) |
25 Health Sciences Drive
Stony Brook, New York 11790
(Address of principal executive offices) (Zip Code)
631-240-8800
(Registrants’ telephone number, including
area code)
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Act:
| Title of each class |
|
Trading
Symbol(s) |
|
Name of each exchange on
which registered |
| Common Stock, $0.001 par value |
|
BNBX |
|
The Nasdaq Stock Market |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Explanatory Note
On May 27, 2026, BNB Plus Corp., a Delaware corporation
(the “Company”), filed a Current Report on Form 8-K (the “Original 8-K”) related to the entry into (1) a Securities
Purchase Agreement (“SPA”) with an accredited investor (the “Purchaser”), pursuant to which the purchaser (“Purchaser”)
agreed to purchase Series B-1 Preferred Stock, and/or Series B-1 Prefunded Warrants in lieu thereof,
and Common Warrants, at an offering price of $1.05 per share for an aggregate subscription amount of $2.5 million, and; (2) Warrant Inducement
and Exchange Agreements (each an “Inducement Agreement”), with certain investors (each an “Exchanging Holder”)
who participated in the Company’s private placements that closed on October 3, 2025 and October 23, 2025 (collectively the “2025
PIPE”), whereby each Exchanging Holder agreed to (i) exercise for cash a certain percentage of outstanding Series E Common Stock
Purchase Warrants (the “Series E Warrants”); (ii) exchange common stock of the Company, par value $0.001 per share (“Common
Stock”); and (iii) exchange pre-funded warrants, held by the Exchanging Holder, to receive convertible preferred stock and other
securities, as described in the Original 8-K.
The Original 8-K described the terms of the transactions
contemplated by the SPA and Inducement Agreements and this Amendment No. 1 to Current Report on Form 8-K/A (this “Amendment”)
is being filed to supplement the Original 8-K to (1) report the total number of Series B-1 Preferred Stock and Common Warrants issued
at the closing of the SPA on May 28, 2026, (2) report the entry into an Inducement Agreement with an additional Exchanging Holder, (3)
update the aggregate amount expected upon exercise of Series E Warrants under the Inducement Agreements, and (4) update the expected timing
of the initial closing of the Inducement Agreement.
Except as expressly set forth herein, this Amendment
does not amend the Original 8-K in any way and does not modify or update any other disclosures contained in the Original 8-K. This Amendment
supplements the Original 8-K and should be read in conjunction with the Original 8-K. Except as defined herein, Capitalized terms have
the same meaning as defined in the Original 8-K.
Item 3.02 Unregistered Sales of Equity Securities
On May 28, 2026, the Company closed the transaction
contemplated by the SPA and sold and issued to the Purchaser, at an offering price of $1.05 per share, 2,380,953 shares of Series B-1
Preferred Stock and Common Warrants to purchase 2,380,953 shares of Common Stock. Gross proceeds from the SPA totaled $2.5 million.
On May 31,
2026, the Company entered into an Inducement Agreement with an Exchanging Holder for an exercise of Series E Warrants in an aggregate
amount of approximately $0.22 million. The initial closing of the Inducement Agreements entered into on May 26, 2026 and May 31, 2026,
for anticipated aggregate gross proceeds of approximately $1.72 million, is expected to occur on or before June 9, 2026.
The issuance by the Company of the Series B-1
Preferred Stock and Common Warrants in connection with the SPA, and the offer of Preferred Stock,
Preferred Stock Shares, Prefunded Warrants, Prefunded Warrant Shares, Rights, Common Warrants, and Common Warrant Shares pursuant
to the SPA and Inducement Agreements, was made in reliance upon the exemption from the registration
requirement of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Section 4(a)(1) thereof and/or Rule
506(b) of Regulation D promulgated thereunder, and applicable state securities laws. The securities that were issued pursuant to
the SPA have not been registered under the Securities Act and such securities may not be offered or sold in the United States absent registration
or an exemption from registration under the Securities Act and any applicable state securities laws.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
BNB Plus Corp. |
| |
|
|
| Date: June 3, 2026 |
By: |
/s/ Clay Shorrock |
| |
Name: |
Clay Shorrock |
| |
Title: |
Chief Executive Officer |